Hongbing Wang

11PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpidemiological modellingBiomolecular modelling and designInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 27, 2025
Potent and Selective Human Constitutive Androstane Receptor Activator DL5055 Facilitates Cyclophosphamide-Based Chemotherapies.

Dongdong Liang, Linhao Li, Yong Ai

|Feb 13, 2025
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity.

Ritika Kurian, Hongbing Wang

|May 20, 2024
Mechanistic Understanding of Dexamethasone-Mediated Protection against Remdesivir-Induced Hepatotoxicity.

Kaiyan Liu, Zhihui Li, Linhao Li

|Jun 10, 2023
Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI.

Sydney Stern, Hongbing Wang, Nakissa Sadrieh

|Feb 22, 2023
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients.

Kaiyan Liu, Sydney Stern, Emily L Heil

|Nov 09, 2022
Phenobarbital in Nuclear Receptor Activation: An Update.

Shuaiqian Men, Hongbing Wang

Pageof 2

Frequent Collaborators

2 joint publications

Scott Heyward

1 joint publications

Melissa Metry

1 joint publications

James E Polli

1 joint publications

Kaiyan Liu